Claims for Patent: 5,384,246

Summary for Patent: 5,384,246

Title:	Determination of ions in fluids by a process involving displacement of indicator ions
Abstract:	A process and a reagent for the determination of ions in fluids, wherein the influence of these ions on the activity of an enzyme is measured. The ions for example are sodium, potassium, calcium, magnesium, manganese, lithium, lead, zinc, copper, iron or other heavy metals or non-metallic ions comprising chloride, bicarbonate, protons, ammonium and substances that give rise to ammonium. The enzymes which are used may be a transferase, a hydrolase, an oxidoreductase or a lyase. An essential feature is a method to exclude interferences by ions by masking the interfering ions with a binding agent.
Inventor(s):	Berry; Michael N. (Eden Hills, AU), Town; Michael-Harold (Oberhausen, DE), Kresse; Georg-Burkhard (Penzberg, DE), Herrmann; Uwe (Bernried, DE)
Assignee:	Boehringer Mannheim GmbH (Mannheim, DE) The Flinders University of South Australia (South Australia, AU)
Application Number:	07/907,732
Patent Claims:	1. Process for the determination of the concentration of an analyte ion in a fluid sample, comprising measuring the activity of an enzyme stimulated by an indicator ion, said enzyme selected from the group consisting of a transferase, a hydrolase, an oxidoreductase or a lyase in the presence of a selective binding agent and said indicator ion, wherein the selective binding agent forms a complex with the indicator ion and the indicator ion is displaced stoichiometrically from the complex by the analyte ion, whereby the displaced indicator ion stimulates the activity of the enzyme, wherein the activity of the enzyme is proportional to the concentration of analyte ion in the fluid sample. 2. Process according to claim 1, wherein said fluid sample is water. 3. Process according to claim 1, wherein said fluid sample is a body fluid. 4. Process according to claim 3, wherein said body fluid is blood, serum, plasma, urine, sweat, exudates or transudates. 5. Process according to claim 3, wherein the enzyme is a transferase transferring phosphorus-containing groups. 6. Process according to claim 5, wherein the transferase is selected from the group consisting of pyruvate kinase, hexokinase, adenylate kinase, pyridoxal kinase or acetate kinase. 7. Process according to claim 3, wherein the enzyme is selected from the group consisting of a hydrolase or a protease. 8. Process according to claim 7, wherein the hydrolase is selected from the group consisting of .alpha.- or .beta.-D-galactosidase, carboxypeptidase A, collagenase, amylase, Calpain I, Calpain II, or dipeptidyl aminopeptidase I (Cathepsin C). 9. Process according to claim 8, wherein the hydrolase is .alpha.- or .beta.-D-galactosidase or carboxypeptidase A. 10. Process according to claim 3, wherein the enzyme is an oxidoreductase. 11. Process according to claim 10, wherein the oxidoreductase is selected from the group consisting of glycerol dehydrogenase, acetaldehyde dehydrogenase or tyrosinase. 12. Process according to claim 3, wherein the enzyme is a lyase. 13. Process according to claim 12, wherein the lyase is a carbon-carbon lyase or a carbon-oxygen lyase. 14. Process according to claim 12, wherein the lyase is aldolase or carbonic anhydrase. 15. Process according to claim 3, wherein the analyte ion is selected from the group consisting of potassium, sodium, calcium, magnesium, manganese, lithium, lead, zinc, copper, iron, chloride, ammonium or substances that give rise to the formation of ammonium. 16. Process according to claim 3, wherein the analyte ion is potassium and the enzyme is selected from the group consisting of pyruvate kinase, glycerol dehydrogenase or acetaldehyde dehydrogenase. 17. Process according to claim 3, wherein the analyte ion is sodium and the enzyme is pyruvate kinase or .beta.-D-galactosidase. 18. Process according to claim 3, wherein the selective binding agent is selected from the group consisting of a cryptand, coronand, podand, crown ether, spherand. hemispherand, calixaren, a natural occurring ionophore, a cyclic peptide, a complexone or a chelating agent, an alkali metal, or an alkaline earth metal. 19. Process according to claim 3, wherein the enzyme is pyruvate kinase, the indicator ion is potassium, the binding agent Kryptofix 221 and the analyte ion is sodium. 20. Process according to claim 3, wherein the enzyme is kinase, the indicator ion is Mg.sup.2+, the binding agent is a chelating agent and the analyte ion is a metal. 21. Process according to claim 3, wherein the enzyme is pyridoxal kinase, the indicator ion is Zn.sup.2+, the binding agent is Kryptofix 221 and the analyte ion is a heavy metal. 22. Process according to claim 3, wherein said selective binding agent is selected from the group consisting of a cryptand and a chelating agent. 23. A composition for the determination of the concentration of an analyte ion in a fluid sample, comprising an indicator ion, an enzyme stimulated by said indicator ion, said enzyme selected from the group consisting of a transferase, a hydrolase, an oxidoreductase or a lyase and a selective binding agent that forms a complex with the indicator ion whereby the indicator ion is displaced stoichiometrically from the complex by said analyte ion in said fluid sample wherein the activity of the enzyme is proportional to the concentration of analyte ion in the fluid sample.

Details for Patent 5,384,246

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2012-01-24